Written by Julianne Orr, PharmD, Indiana University Health Simon Cancer Center
Download Here

Olanzapine (Zyprexa) is an FDA approved atypical antipsychotic that blocks multiple neuronal receptors involved in nausea/vomiting pathways.  This PQI will review the appropriate use of olanzapine for prevention and treatment of CINV.
Continue reading Olanzapine (Zyprexa) in Chemotherapy Induced Nausea and Vomiting

Read More